008: Commitment To GMP With Dr. Shabbir Anik
Business Of Biotech
00:00
Sutros' Proprietary Platform for Protein Manufacturing
Sutros has been existence almost over 15 years. The challenge there was that to develop that process of extracting the machinery was not something that you could go out and I have a CVMO do. So, trying to use an external CDM approach is really not fact that the other piece being that we really wanted to keep the technology and the understanding as proprietary as possible. We are able to introduce certain non natural amino acids into the antibody itself, which then allows us to create site specific conjugation. That's the platform that we currently have in terms of developing antibody drug conjugates.
Play episode from 15:12
Transcript
